Clinical Trial Update: Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS [Phase 2]

View source ↗

Summary

Phase 2 trial update of azacitidine plus lenalidomide in elderly patients with previously treated acute myeloid leukemia and high-risk myelodysplastic syndromes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Stanford University | Conditions: Leukemia, Acute Myeloid Leukemia (AML) | Phase 2 | Status: TERMINATED | Results posted: 2018-01-03